RAYMOND JAMES & ASSOCIATES - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 45 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q1 2022$18,000
+28.6%
22,000
+63.0%
0.00%
Q4 2021$14,000
+27.3%
13,500
-20.6%
0.00%
Q3 2019$11,0000.0%17,000
+36.0%
0.00%
Q2 2019$11,000
-88.8%
12,500
-64.7%
0.00%
Q1 2017$98,00035,4400.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Boxer Capital, LLC 10,188,312$11,105,0001.28%
Stonepine Capital Management, LLC 2,008,006$2,189,0001.26%
CVI Holdings, LLC 909,625$991,0000.94%
Vivo Capital, LLC 6,818,181$7,432,0000.74%
Broadfin Capital, LLC 2,727,272$2,973,0000.61%
Telemetry Investments, L.L.C. 650,000$708,0000.36%
Granite Point Capital Management, L.P. 1,706,134$1,860,0000.18%
J. Goldman & Co LP 1,045,000$1,139,0000.06%
Tibra Equities Europe Ltd 241,966$264,0000.03%
IPG Investment Advisors LLC 42,500$46,325,0000.02%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders